JANNSSEN PHARMACEUTICALS COB SIGNED.PDF

RESOLUTION: C-26-18-008-3-00
OUTPATIENT SAMPLE PROGRAM WITH JANSSEN PHARMACEUTICALS, INC.
LONG ACTING INJECTABLE ANTIPSYCHOTIC MEDICATIONS
WHEREAS, an average of 200 inmate patients per month receive long acting injectable antipsychotic
("LAI") medications comprising of 20% of the monthly pharmacy budget for a jail population of 7500;
WHEREAS, recent medical literature indicates that adherence to antipsychotic medication may lead to a
decrease in criminal recidivism, and where patients are carefully selected for LAI treatment, in
combination with discharge planning and "warm handoffs," there is the potential of decreasing the
recidivism of this vulnerable patient population;
WHEREAS, partnering with pharmaceutical companies to receive LAI medications free-of-charge,
Maricopa County Correctional Health Services will be able to continue these treatments on stable patients
and to initiate therapy on candidates who may benefit the most;
NOW THEREFORE:
BE IT RESOLVED that the Board of Supervisors hereby adopts Resolution: C-26-18-008-3-00 and
authorizes Maricopa County by and through its Department of Correctional Health Services (MCDCHS),
to process a non-financial Outpatient Sample Program (OSP) form (1050041-SUS170114941) with
Janssen Pharmaceuticals, Inc., for free samples of INVEGA SUSTENNA® (paliperidone palmitate), up to
six (6) units per dosage, 156 mg and 234 mg.
Dated this G*IA day of °V , 2018.
IN WITNESS WHEREOF, the parties agree to enter into this agreement:
APPROVED AS TO FORM: FOR AND ON BEHALF OF
MARICOP-A-COUNTY
I
A orney for Maricopa County By
Chairman, Board of Supervisors
tt i2t 1 S7
NOV 2 8 2f110
Date
Date
ATTEST:
vka)tc Clerk of the Board 0(091/4-10(
NOV 2 3 2,{111
Date

RESOLUTION: C-26-18-008-3-00
OUTPATIENT SAMPLE PROGRAM WITH JANSSEN PHARMACEUTICALS, INC.
LONG ACTING INJECTABLE ANTIPSYCHOTIC MEDICATIONS
WHEREAS, an average of 200 inmate patients per month receive long acting injectable antipsychotic
("LAI") medications comprising of 20% of the monthly pharmacy budget for a jail population of 7500;
WHEREAS, recent medical literature indicates that adherence to antipsychotic medication may lead to a
decrease in criminal recidivism, and where patients are carefully selected for LAI treatment, in
combination with discharge planning and "warm handoffs," there is the potential of decreasing the
recidivism of this vulnerable patient population;
WHEREAS, partnering with pharmaceutical companies to receive LAI medications free-of-charge,
Maricopa County Correctional Health Services will be able to continue these treatments on stable patients
and to initiate therapy on candidates who may benefit the most;
NOW THEREFORE:
BE IT RESOLVED that the Board of Supervisors hereby adopts Resolution: C-26-18-008-3-00 and
authorizes Maricopa County by and through its Department of Correctional Health Services (MCDCHS),
to process a non-financial Outpatient Sample Program (OSP) form (1050041-SUS170114941) with
Janssen Pharmaceuticals, Inc., for free samples of INVEGA SUSTENNA® (paliperidone palmitate), up to
six (6) units per dosage, 156 mg and 234 mg.
Dated this al-0k day of dale"34--{ , 2018.
IN WITNESS WHEREOF, the parties agree to enter into this agreement:
APPROVED AS TO FORM: FOR AND ON BEHALF OF
MARICOP OUNTY
A orney for Maricopa County
t t
Date NOV 2 8
Date
ATTEST:
Clerk of the Board OuVIVI
/5 NOV 28 Mt
Date